Ftse Mib
38.472,56
0,13%
DAX
22.425,93
0,73%
S&P 500
5.983,25
-0,50%
NASDAQ
19.286,92
-1,21%
Bitcoin
92.005,90
0,62%
Pepperstone
Advertisement
Registration Strip Icon for default Registrati gratuitamente per ottenere quotazioni in tempo reale, grafici interattivi, flusso di opzioni in tempo reale e altro ancora.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. AMEX Armata Pharmaceuticals Inc (ARMP) Armata Pharmaceuticals Inc (ARMP) Notizie

ARMP

Armata Pharmaceuticals (ARMP)

HOME News News di Agenzia

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:AMEX:ARMP
DataOraFonteTitoloSimboloCompagnia
07/02/202522:22Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesAMEX:ARMPArmata Pharmaceuticals Inc
19/12/202413:38Edgar (US Regulatory)Form 8-K - Current reportAMEX:ARMPArmata Pharmaceuticals Inc
14/11/202422:17Edgar (US Regulatory)Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]AMEX:ARMPArmata Pharmaceuticals Inc
13/11/202422:15Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]AMEX:ARMPArmata Pharmaceuticals Inc
19/08/202422:15Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesAMEX:ARMPArmata Pharmaceuticals Inc
04/03/202423:35Edgar (US Regulatory)Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]AMEX:ARMPArmata Pharmaceuticals Inc
23/01/202422:17Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansAMEX:ARMPArmata Pharmaceuticals Inc
03/08/202322:37Edgar (US Regulatory)Form ARS - Annual Report to Security HoldersAMEX:ARMPArmata Pharmaceuticals Inc
03/08/202322:35Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialAMEX:ARMPArmata Pharmaceuticals Inc
03/08/202322:34Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsAMEX:ARMPArmata Pharmaceuticals Inc
24/07/202322:30Edgar (US Regulatory)Form PRE 14A - Other preliminary proxy statementsAMEX:ARMPArmata Pharmaceuticals Inc
27/06/202322:31Edgar (US Regulatory)Current Report Filing (8-k)AMEX:ARMPArmata Pharmaceuticals Inc
11/05/202322:07Edgar (US Regulatory)Quarterly Report (10-q)AMEX:ARMPArmata Pharmaceuticals Inc
16/03/202321:07Edgar (US Regulatory)Annual Report (10-k)AMEX:ARMPArmata Pharmaceuticals Inc
13/02/202321:42Edgar (US Regulatory)Securities Registration Statement (simplified Form) (s-3)AMEX:ARMPArmata Pharmaceuticals Inc
07/02/202322:01Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)AMEX:ARMPArmata Pharmaceuticals Inc
10/11/202212:25TipRanksH.C. Wainwright Keeps Their Buy Rating on Armata Pharmaceuticals (ARMP)AMEX:ARMPArmata Pharmaceuticals Inc
15/08/202213:45TipRanksLadenburg Thalmann & Co. Remains a Buy on Armata Pharmaceuticals (ARMP)AMEX:ARMPArmata Pharmaceuticals Inc
12/08/202212:25TipRanksH.C. Wainwright Sticks to Their Buy Rating for Armata Pharmaceuticals (ARMP)AMEX:ARMPArmata Pharmaceuticals Inc
01/08/202215:28TipRanksArmata Pharmaceuticals (ARMP) Receives a Buy from H.C. WainwrightAMEX:ARMPArmata Pharmaceuticals Inc
01/06/202212:03Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)AMEX:ARMPArmata Pharmaceuticals Inc
24/05/202212:02Edgar (US Regulatory)Securities Registration Statement (simplified Form) (s-3/a)AMEX:ARMPArmata Pharmaceuticals Inc
16/05/202212:45TipRanksArmata Pharmaceuticals (ARMP) Gets a Buy Rating from Ladenburg Thalmann & Co.AMEX:ARMPArmata Pharmaceuticals Inc
15/04/202221:57Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)AMEX:ARMPArmata Pharmaceuticals Inc
01/04/202222:51Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)AMEX:ARMPArmata Pharmaceuticals Inc
18/03/202211:35TipRanksWall Street Analysts Are Bullish on Top Healthcare PicksAMEX:ARMPArmata Pharmaceuticals Inc
24/02/202222:07Edgar (US Regulatory)Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a)AMEX:ARMPArmata Pharmaceuticals Inc
07/01/202213:55TipRanksLadenburg Thalmann & Co. Keeps Their Buy Rating on Armata Pharmaceuticals (ARMP)AMEX:ARMPArmata Pharmaceuticals Inc
05/01/202216:35TipRanksH.C. Wainwright Maintains Their Buy Rating on Armata Pharmaceuticals (ARMP)AMEX:ARMPArmata Pharmaceuticals Inc
22/04/202112:01Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)AMEX:ARMPArmata Pharmaceuticals Inc
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:AMEX:ARMP

La tua Cronologia

BIT
SPM
Saipem
BIT
UCG
Unicredit
BIT
STLAM
Stellantis NV
BIT
ISP
Intesa Sanpaolo
BIT
BMPS
Banca Monte Dei Paschi D...
BIT
LDO
Leonardo
BIT
ENEL
Enel
BIT
BPE
Bper Banca
BIT
PRY
Prysmian
BIT
STMMI
ST Microelectronics
BIT
BAMI
Banco BPM
BIT
ENI
Eni
BIT
TIT
Telecom Italia
BIT
RACE
Ferrari NV
BIT
G
Generali
BIT
CPR
Davide Campari
Delayed Upgrade Clock
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network

Rimuovi gli annunci

Iscriviti per un'esperienza senza pubblicità

Nessuna pubblicità

Prova adesso

Conserva gli annunci